Ruth Ladenstein

13.2k total citations
204 papers, 5.5k citations indexed

About

Ruth Ladenstein is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Ruth Ladenstein has authored 204 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 127 papers in Neurology, 58 papers in Pulmonary and Respiratory Medicine and 58 papers in Cancer Research. Recurrent topics in Ruth Ladenstein's work include Neuroblastoma Research and Treatments (127 papers), Cancer, Hypoxia, and Metabolism (55 papers) and Sarcoma Diagnosis and Treatment (53 papers). Ruth Ladenstein is often cited by papers focused on Neuroblastoma Research and Treatments (127 papers), Cancer, Hypoxia, and Metabolism (55 papers) and Sarcoma Diagnosis and Treatment (53 papers). Ruth Ladenstein collaborates with scholars based in Austria, Germany and France. Ruth Ladenstein's co-authors include Peter F. Ambros, Andrew D.J. Pearson, Jean Michon, Helmut Gadner, Victoria Castel, Susan L. Cohn, Katherine K. Matthay, Uta Dirksen, Ulrike Pötschger and Dominique Valteau‐Couanet and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Ruth Ladenstein

192 papers receiving 5.4k citations

Peers

Countries citing papers authored by Ruth Ladenstein

Since Specialization

Citations

This map shows the geographic impact of Ruth Ladenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Ladenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Ladenstein more than expected).

Fields of papers citing papers by Ruth Ladenstein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Ladenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Ladenstein. The network helps show where Ruth Ladenstein may publish in the future.

Co-authorship network of co-authors of Ruth Ladenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Ladenstein. A scholar is included among the top collaborators of Ruth Ladenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Ladenstein. Ruth Ladenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Primary Mediastinal Ewing’s Sarcoma: Post Hoc Analysis from Two International Multicenter Prospective Randomized Trials 2025 ·Cancers ·Theresa Störk, Andreas Ranft, Clemens Aigner, Heribert Jürgens, Ruth Ladenstein, Beate Timmermann, Henk van den Berg, Uta Dirksen, Stéphane Collaud	0
2	Twinning to reduce research and innovation inequalities in paediatric solid tumours across Europe 2024 ·SHILAP Revista de lepidopterología ·Jelena Rascon, (unknown), (unknown), Sabine Taschner‐Mandl, (unknown), (unknown), Stefan Rutkowski, Ulrich Schüller, Karsten Nysom, Ruta Tuckuviene, Jesper Brok, Kjeld Schmiegelow, Marry M. van den Heuvel‐Eibrink, (unknown), Riccardo Haupt, Monica Muraca, Davide Saraceno, Birgit Geoerger, (unknown), Ruth Ladenstein	0
3	Use Cases Requiring Privacy-Preserving Record Linkage in Paediatric Oncology 2024 ·Cancers ·Dieter Hayn, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Priyanka Devi-Marulkar, Gudrun Schleiermacher, Ruth Ladenstein, G. Schreier	2
4	Overall survival prediction and risk stratification in patients with neuroblastoma through machine learning in the large multi-institutional PRIMAGE cohort. 2024 ·Journal of Clinical Oncology ·(unknown), Ana Jiménez-Pastor, Glen J. Weiss, Leonor Cerdá-Alberich, (unknown), (unknown), Barbara Hero, Ruth Ladenstein, Luis Martí‐Bonmatí, Ángel Alberich‐Bayarri	0
5	Reproducibility Analysis of Radiomic Features on T2-weighted MR Images after Processing and Segmentation Alterations in Neuroblastoma Tumors 2024 ·Radiology Artificial Intelligence ·(unknown), (unknown), L. Cerdá Alberich, Ana Jiménez-Pastor, (unknown), José Miguel Carot Sierra, (unknown), (unknown), Ulrike Pötschger, Sabine Taschner‐Mandl, Emanuele Neri, Adela Cañete, Ruth Ladenstein, Barbara Hero, Ángel Alberich‐Bayarri, Luis Martí‐Bonmatí	0
6	Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials 2023 ·Cancers ·Lars Tramsen, Konrad Bochennek, Monika Sparber‐Sauer, Emilia Salzmann‐Manrique, Monika Scheer, Tobias M. Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner, Martin Ebinger, (unknown), Ruth Ladenstein, Gustaf Ljungman, Erika Hallmen, Thomas Lehrnbecher, Ewa Kościelniak, Thomas Klingebiel	13
7	Multimodal Therapy with Consolidating Haploidentical Stem Cell Transplantation and Dinutuximab Beta for Patients with High-Risk Neuroblastoma and Central Nervous System Relapse 2023 ·Journal of Clinical Medicine ·(unknown), Martin Ebinger, (unknown), Ruth Ladenstein, Thorsten Simon, Holger N. Lode, Barbara Hero, Martin U. Schuhmann, Jürgen Schäfer, Frank Paulsen, Beate Timmermann, Angelika Eggert, Peter Lang	4
8	Independent Validation of a Deep Learning nnU-Net Tool for Neuroblastoma Detection and Segmentation in MR Images 2023 ·Cancers ·(unknown), L. Cerdá Alberich, Ana Jiménez-Pastor, José Miguel Carot Sierra, (unknown), (unknown), (unknown), (unknown), Sabine Taschner‐Mandl, (unknown), Ulrike Pötschger, Thorsten Simon, Emanuele Neri, Ángel Alberich‐Bayarri, Adela Cañete, Barbara Hero, Ruth Ladenstein, Luis Martí‐Bonmatí	12
9	Effect and Tolerance of N5 and N6 Chemotherapy Cycles in Combination with Dinutuximab Beta in Relapsed High-Risk Neuroblastoma Patients Who Failed at Least One Second-Line Therapy 2023 ·Cancers ·Holger N. Lode, Ruth Ladenstein, (unknown), (unknown), Nikolai Siebert, (unknown), Karoline Ehlert, (unknown), Evgenia Glogova, Patrick Hundsdoerfer, Angelika Eggert, (unknown), Walentyna Balwierz, Aleksandra Wieczorek	2
10	Comparative Multicentric Evaluation of Inter-Observer Variability in Manual and Automatic Segmentation of Neuroblastic Tumors in Magnetic Resonance Images 2022 ·Cancers ·(unknown), L. Cerdá Alberich, (unknown), (unknown), Ulrike Pötschger, Michela Gabelloni, José Miguel Carot Sierra, Sabine Taschner‐Mandl, (unknown), Adela Cañete, Ruth Ladenstein, Emanuele Neri, Luis Martí‐Bonmatí	26
11	Clinical Phenotype and Management of Severe Neurotoxicity Observed in Patients with Neuroblastoma Treated with Dinutuximab Beta in Clinical Trials 2022 ·Cancers ·Aleksandra Wieczorek, Carla Manzitti, Alberto Garaventa, Juliet C. Gray, Vassilios Papadakis, Dominique Valteau‐Couanet, Katarzyna Zachwieja, Ulrike Pöetschger, Ingrid Pribill, (unknown), Ruth Ladenstein, Holger N. Lode	12
12	The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project 2020 ·Pediatric Blood & Cancer ·V. V. Moroz, David Machin, Barbara Hero, Ruth Ladenstein, Frank Berthold, (unknown), (unknown), Andrew D.J. Pearson, Susan L. Cohn, Wendy B. London	32
13	Low CD4⁺/CD25⁺/CD127⁻ regulatory T cell- and high INF-γ levels are associated with improved survival of neuroblastoma patients treated with long-term infusion of ch14.18/CHO combined with interleukin-2 2019 ·OncoImmunology ·(unknown), Nikolai Siebert, (unknown), (unknown), Karoline Ehlert, (unknown), Hans Loibner, Ruth Ladenstein, Holger N. Lode	18
14	Impact of Disseminated Neuroblastoma Cells on the Identification of the Relapse-Seeding Clone 2017 ·Clinical Cancer Research ·Mojtaba Abbasi, Fikret Rifatbegovic, (unknown), Georg Mann, (unknown), Ulrike Pötschger, Roman Crazzolara, Marek Ussowicz, Martin Benesch, (unknown), Godfrey Chi Fung Chan, Neil D. Jones, Ruth Ladenstein, Inge M. Ambros, Peter F. Ambros	25
15	Tolerability, response and outcome of high-risk neuroblastoma patients treated with long-term infusion of anti-GD₂ antibody ch14.18/CHO 2017 ·mAbs ·(unknown), Karoline Ehlert, (unknown), (unknown), Nikolai Siebert, Silke Kietz, Penelope Brock, Alberto Garaventa, Dominique Valteau‐Couanet, Evelyne Janzek, Norbert Hosten, (unknown), Winfried Barthlen, (unknown), Hans Loibner, Ruth Ladenstein, Holger N. Lode	52
16	Standardized data sharing in a paediatric oncology research network--a proof-of-concept study. 2015 ·PubMed ·(unknown), (unknown), (unknown), Stefan Welte, Dieter Hayn, Lefteris Koumakis, George Potamias, Manolis Tsiknakis, Davide Saraceno, Eugenia Rinaldi, Ruth Ladenstein, G. Schreier	5
17	THE ROLE OF MEGATHERAPY (MGT) AND STEM CELL TRANSPLANTATION (SCT) IN HIGH RISK EWING TUMORS (ET): MORE THAN 30 YEARS OF EBMT ACTIVITY 2014 ·mediaTUM (Technical University of Munich) ·Ruth Ladenstein, D Valteau-Couanet, Evgenia Glogova, H. Juergens, S. Burdach, Jean Michon, H. van den Berg, Ian Lewis, I. Yaniv, Christina Peters	1
18	Clinical and Biologic Features Predictive of Survival After Relapse of Neuroblastoma: A Report From the International Neuroblastoma Risk Group Project 2011 ·Journal of Clinical Oncology ·Wendy B. London, Victoria Castel, Tom Monclair, Peter F. Ambros, Andrew D.J. Pearson, Susan L. Cohn, Frank Berthold, Akira Nakagawara, Ruth Ladenstein, Tomoko Iehara, Katherine K. Matthay	229
19	Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study 2011 ·IRIS ·Ruth Ladenstein, Ulrike Pöetschger, Roberto Luksch, Penelope Brock, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Geneviève Laureys, Josef Mališ, Walentyna Balwierz, Ellen Ruud, Per Kogner, (unknown), (unknown), Maja Beck‐Popovic, (unknown), Miklós Garami, Toby N. Trahair, D Valteau-Couanet	1
20	Primary Disseminated Multifocal Ewing Sarcoma: Results of the Euro-EWING 99 Trial 2010 ·Journal of Clinical Oncology ·Ruth Ladenstein, Ulrike Pötschger, Marie‐Cécile Le Deley, Jeremy Whelan, Michael Paulussen, Odile Oberlin, Henk van den Berg, Uta Dirksen, Lars Hjorth, Jean Michon, Ian Lewis, Alan Craft, Heribert Jürgens	350

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact